Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013247	li-/s-alb	mg/g (mg/g)	938	1002	0.00%
3013247	li-/s-alb	— (—)	57	58	100.00%	Distribution not available
3013247	s-alb	mg/g (mg/g)	6	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other degenerative diseases of the nervous system

278

66.04

307.65

1.0

5.59

5.71

mg/g

0.08

258

Other demyelinating diseases of the central nervous system

141

77.61

262.68

1.0

1.1

4.97

5.47

mg/g

0.38

132

Disturbances of skin sensation

234

232

10.24

208.20

1.1

1.0

5.69

6.68

mg/g

1.15

221

219

Neurological diseases

312

154

10.22

186.29

1.1

1.0

6.20

6.28

mg/g

0.05

298

148

Visual disturbances

231

373

6.24

135.91

1.1

7.18

6.79

mg/g

0.15

221

355

Visual disturbances and blindness

237

403

5.92

132.21

1.1

7.16

6.75

mg/g

0.16

226

384

Autoimmune diseases related-to ILD

329

623

4.54

129.13

1.0

1.1

5.75

7.66

mg/g

3.55

306

600

Optic neuritis

31.10

126.32

1.0

4.77

5.59

mg/g

0.89

Symptoms and signs involving the nervous and musculoskeletal systems

240

450

5.36

120.60

1.1

6.86

7.02

mg/g

0.11

223

432

Symptoms and signs involving the skin and subcutaneous tissue

276

585

4.64

116.42

1.1

5.94

6.94

mg/g

1.69

262

555

Autoimmune diseases excluding thyroid diseases

367

501

4.01

104.53

1.1

6.73

7.22

mg/g

0.36

344

481

ILD medications: immunosuppressive drugs

250

507

4.60

102.77

1.1

6.54

7.46

mg/g

0.82

238

483

Autoimmune diseases excluding thyroid diseases, strict definition

357

491

4.00

101.37

1.1

6.71

7.28

mg/g

0.42

334

471

Abnormal findings on diagnostic imaging of central nervous system

26.45

99.65

1.1

1.0

5.55

5.69

mg/g

0.08

ILD medications

343

565

3.30

75.03

1.1

6.23

7.24

mg/g

1.13

324

538

Subjective visual disturbances

113

162

7.03

74.67

1.0

1.1

7.37

7.02

mg/g

0.06

107

156

Headache

228

482

3.79

69.64

1.1

1.0

7.01

6.48

mg/g

0.22

216

460

Other neurological diseases

206

403

4.03

68.01

1.1

8.41

7.21

mg/g

0.48

197

381

L04AA Selective immunosuppressants

115

192

6.04

65.68

1.0

1.1

5.23

7.22

mg/g

2.69

109

181

Autoimmune diseases

316

501

3.22

65.01

1.1

6.47

7.22

mg/g

0.61

298

481

Used for control exclusion in common control thyroid runs

287

475

3.06

54.65

1.1

6.60

7.29

mg/g

0.50

270

456

Symptoms and signs involving cognition, perception, emotional state and behaviour

268

630

2.91

51.83

1.1

6.60

6.93

mg/g

0.34

251

601

Other symptoms and signs involving the nervous and musculoskeletal systems

135

331

4.10

49.21

1.1

1.0

5.70

6.40

mg/g

0.89

126

316

General symptoms and signs

284

508

2.81

46.83

1.1

1.0

7.32

6.62

mg/g

0.35

266

486

Cerebrovascular diseases (FINNGEN)

118

182

4.61

44.39

1.1

7.49

6.96

mg/g

0.32

112

169

Malaise and fatigue

134

279

3.88

42.57

1.1

1.0

7.49

6.99

mg/g

0.32

125

266

Cerebrovascular diseases

158

314

3.54

42.36

1.1

7.61

8.03

mg/g

0.28

148

295

Other symptoms and signs involving cognitive functions and awareness

103

212

4.44

40.60

1.1

7.94

8.11

mg/g

0.07

202

Pain in limb

230

558

2.76

40.59

1.1

7.02

6.42

mg/g

0.49

219

535

Second line medication for Crohn's disease

168

563

2.99

37.96

1.1

7.12

6.69

mg/g

0.35

159

531

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

147

406

3.25

37.13

1.1

6.62

7.86

mg/g

1.39

141

382

Dizziness and giddiness

177

475

2.96

37.08

1.1

6.10

7.07

mg/g

1.29

164

450

L04AX Other immunosuppressants

164

550

2.99

37.02

1.1

7.15

6.75

mg/g

0.32

155

518

Other soft tissue disorders, not elsewhere classified

247

581

2.50

34.58

1.1

6.63

6.83

mg/g

0.12

233

557

Stroke, including SAH

121

240

3.67

34.51

1.1

7.77

8.60

mg/g

0.52

115

226

Stroke, excluding SAH

114

221

3.77

33.94

1.1

7.64

8.47

mg/g

0.55

108

207

ILD medications: prednisolone, methylprednisolone, prednisone

243

545

2.50

33.62

1.1

6.66

7.34

mg/g

0.57

227

520

Ischaemic Stroke, excluding all haemorrhages

103

195

3.94

32.72

1.1

7.48

8.81

mg/g

0.95

183

STROKE

138

291

3.23

32.02

1.1

7.80

7.44

mg/g

0.21

129

276

Diseases of the eye and adnexa

215

409

2.64

31.94

1.0

1.1

5.75

6.93

mg/g

1.83

206

389

Migraine

159

458

2.82

30.88

1.1

1.0

5.41

6.11

mg/g

0.98

148

436

Mood disorders, excluding more controls

216

522

2.47

29.96

1.1

6.24

7.28

mg/g

1.51

205

499

Anxiety disorders, excluding more controls

196

512

2.50

28.37

1.1

6.10

7.15

mg/g

1.49

182

488

Mood [affective] disorders

239

700

2.22

26.65

1.1

6.01

7.43

mg/g

2.20

228

665

Mood disorders

239

700

2.21

26.54

1.1

6.01

7.43

mg/g

2.20

228

665

Depression

226

693

2.21

25.44

1.1

6.06

7.38

mg/g

1.86

217

658

Episodal and paroxysmal disorders

248

575

2.20

25.41

1.1

5.97

7.18

mg/g

1.44

234

547

Other headache syndromes

114

391

2.92

24.89

1.1

1.0

7.20

6.42

mg/g

0.54

107

370

Anxiety (asthma-related co-morbidities)

173

556

2.41

24.45

1.1

5.65

7.33

mg/g

2.28

167

524

Anxiety disorders

217

692

2.19

23.97

1.1

6.06

7.26

mg/g

1.60

202

663

Disorders of ocular muscles, binocular movement, accommodation and refraction

137

530

2.57

23.38

1.1

7.08

6.27

mg/g

0.21

130

504

Neurotic, stress-related and somatoform disorders

214

695

2.16

22.88

1.1

6.07

7.26

mg/g

1.56

199

666

Spirochaetal infections, other/unspecified

214

3.52

22.28

1.1

1.0

8.71

6.76

mg/g

1.07

202

Condition for Implicit Sepsis (Organ dysfunction codes)

198

620

2.21

22.26

1.1

7.42

6.54

mg/g

0.84

185

592

Any mental disorder

227

528

2.16

22.19

1.1

6.28

7.25

mg/g

1.26

214

503

Extrapyramidal and movement disorders

220

3.46

22.08

1.2

1.0

6.16

7.72

mg/g

1.29

206

Other spirochaetal diseases

221

3.45

21.94

1.1

1.0

8.71

6.68

mg/g

1.17

209

Migraine with aura

262

3.22

21.70

1.1

1.0

5.23

5.68

mg/g

0.53

252

Lyme disease

214

3.47

21.55

1.1

1.0

8.79

6.75

mg/g

1.13

202

Pain in joint

131

315

2.66

21.49

1.1

6.84

6.65

mg/g

0.10

123

300

All anxiety disorders

175

614

2.26

21.47

1.1

5.62

6.99

mg/g

1.84

169

586

Other spirochaetal diseases

220

3.42

21.38

1.1

1.0

8.79

6.67

mg/g

1.23

208

Implicit Sepsis

168

538

2.29

20.89

1.1

7.40

6.72

mg/g

0.53

158

512

Cerebral cysts

7.40

20.79

1.0

14.06

6.37

mg/g

0.56

Epilepsy

243

3.25

20.77

1.1

1.0

6.73

6.94

mg/g

0.11

235

First line medication for Crohn's disease

245

657

2.02

20.73

1.1

1.0

7.89

6.39

mg/g

0.86

233

625

Other anxiety disorders

140

506

2.40

20.25

1.1

1.0

5.68

6.71

mg/g

0.98

132

482

Condition for Implicit Sepsis (Organ dysfunction codes)

175

561

2.20

19.86

1.1

7.46

6.74

mg/g

0.57

165

535

Recurrent or chronic depression

109

280

2.74

19.57

1.1

5.70

6.74

mg/g

1.35

103

265

Guillain-Barre syndrome

32.53

19.40

1.3

1.0

19.01

5.88

mg/g

—

Meningitis

8.42

19.27

1.1

1.0

12.14

8.15

mg/g

0.91

Tramadol

161

457

2.17

17.03

1.1

1.0

7.25

6.80

mg/g

0.34

151

431

Opioids

209

556

1.96

16.19

1.1

1.0

6.28

6.79

mg/g

0.44

199

525

Special screening examination for infectious and parasitic diseases

232

2.77

16.19

1.1

6.50

5.66

mg/g

0.85

221

Depression or dysthymia

133

317

2.32

16.01

1.1

6.69

7.20

mg/g

0.35

126

302

Soft tissue disorders

219

589

1.92

16.01

1.1

6.30

6.83

mg/g

0.44

204

564

Nerve, nerve root and plexus disorders

206

656

1.93

15.95

1.1

7.07

6.87

mg/g

0.13

189

629

Inflammatory bowel disease treatment related agents

235

710

1.85

15.88

1.1

6.64

7.03

mg/g

0.35

221

676

Migraine without aura

232

2.99

15.83

1.1

1.0

5.78

5.57

mg/g

0.11

223

Syncope and collapse

237

2.82

15.64

1.1

1.0

6.77

7.30

mg/g

0.31

229

Papilloedema, unspecified

19.64

15.61

1.1

1.0

16.67

5.89

mg/g

0.62

Other dorsopathies, not elsewhere classified

214

591

1.90

15.28

1.1

6.77

6.76

mg/g

0.00

201

563

Examination and observation for other reasons

126

316

2.31

15.28

1.1

7.01

6.16

mg/g

0.81

121

303

Symptoms and signs involving speech and voice

226

2.93

14.68

1.0

7.06

7.13

mg/g

0.03

213

Codeine

192

545

1.92

14.30

1.1

1.0

6.61

6.78

mg/g

0.11

184

515

Small fibre neuropathy

19.45

14.26

1.0

8.63

7.17

mg/g

0.40

Psychiatric diseases

187

487

1.93

13.83

1.0

1.1

6.24

7.11

mg/g

0.94

176

461

Dorsalgia

203

589

1.85

13.55

1.1

6.59

6.73

mg/g

0.09

189

561

Myalgia

189

3.03

13.45

1.0

5.46

5.98

mg/g

0.38

183

Oral corticosteroids

206

674

1.82

13.33

1.1

6.59

7.14

mg/g

0.51

192

642

Implicit Sepsis

133

490

2.05

12.95

1.1

7.53

6.96

mg/g

0.33

126

467

Certain infectious and parasitic diseases

196

531

1.85

12.94

1.1

1.0

6.89

6.35

mg/g

0.36

183

507

Other antidepressants

191

531

1.84

12.58

1.1

6.43

7.39

mg/g

0.89

182

502

Other diseases of urinary system

192

592

1.82

12.51

1.1

7.00

6.43

mg/g

0.40

180

568

Pain (limb, back, neck, head abdominally)

134

323

2.08

12.29

1.1

6.81

6.56

mg/g

0.15

127

307

Medical observation and evaluation for suspected diseases and conditions

129

318

2.08

11.86

1.1

6.60

6.16

mg/g

0.26

124

305

Systemic connective tissue disorders

254

2.60

11.86

1.0

1.1

6.93

6.83

mg/g

0.04

240

Sixth [abducent] nerve palsy

14.81

11.80

1.1

1.0

5.53

6.65

mg/g

0.56

Cystitis

160

504

1.89

11.80

1.1

7.19

6.34

mg/g

0.68

151

484

Diarrhoea and gastroenteritis of presumed infectious origin

195

737

1.75

11.44

1.1

6.60

7.04

mg/g

0.35

186

698

Disorders of lacrimal system

343

2.33

11.36

1.1

1.0

6.54

6.66

mg/g

0.06

322

Codeine or tramadol medication

214

685

1.71

11.24

1.1

6.48

7.07

mg/g

0.57

203

650

Dorsopathies

205

600

1.74

11.18

1.1

6.72

6.76

mg/g

0.02

192

572

Exposure to unspecified factor

192

800

1.73

11.09

1.1

7.12

6.93

mg/g

0.11

182

760

Dysphagia

151

2.99

10.49

1.1

1.0

8.99

7.67

mg/g

0.34

144

Persons encountering health services in other circumstances, wide

213

653

1.68

10.39

1.1

7.38

7.10

mg/g

0.16

203

619

Use of dimethyl fumarate

19.57

10.36

1.0

5.45

5.58

mg/g

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

202

653

1.68

10.04

1.1

7.31

7.10

mg/g

0.11

194

619

Intestinal infectious diseases

211

730

1.65

9.92

1.1

6.88

7.03

mg/g

0.08

202

691

Paraplegia, diplegia of upper limbs

16.95

9.90

1.2

1.0

13.04

7.00

mg/g

—

Symptoms and signs involving the circulatory and respiratory systems

205

618

1.66

9.60

1.1

6.87

6.94

mg/g

0.02

196

589

Cerebral arteritis

+∞

9.52

2.0

0.0

10.23

—

mg/g

—

Symptoms and signs involving the urinary system

125

514

1.85

9.31

1.1

8.97

6.82

mg/g

1.49

118

487

Triptan medication for migraine, single purchase ok

165

652

1.72

9.27

1.1

5.96

6.90

mg/g

0.97

160

615

Migraine, single triptan purchase ok & required. ICD-code if available is included

165

652

1.72

9.27

1.1

5.96

6.90

mg/g

0.97

160

615

Hard cardiovascular diseases

138

452

1.82

9.24

1.1

7.69

7.40

mg/g

0.17

128

430

Other disorders of urethra and urinary system

121

470

1.86

9.02

1.1

1.0

7.19

6.40

mg/g

0.37

111

450

Other reaction to severe stress, and adjustment disorders

436

2.02

8.88

1.1

1.0

5.81

6.00

mg/g

0.12

416

Selective serotonin reuptake inhibitors

174

537

1.69

8.83

1.1

6.95

7.39

mg/g

0.27

167

508

Other special examinations and investigations of persons without complaint or reported diagnosis

119

318

1.90

8.67

1.0

1.1

6.23

6.16

mg/g

0.04

110

305

Disorders of optic nerve, not elsewhere classified

20.29

8.49

1.2

1.0

6.94

7.19

mg/g

—

Low back pain

136

560

1.75

8.27

1.1

6.15

6.32

mg/g

0.14

129

533

Certain infectious and parasitic diseases

133

371

1.80

8.23

1.1

1.0

7.34

6.42

mg/g

0.51

124

356

GASTRO-related operations

163

484

1.69

8.19

1.1

6.20

6.66

mg/g

0.30

154

464

Any gastric operation

163

484

1.69

8.19

1.1

6.20

6.66

mg/g

0.30

154

464

Use of fingolimod

17.69

8.13

1.1

1.0

4.53

6.36

mg/g

—

Myasthenia gravis

22.36

8.04

1.0

6.60

6.52

mg/g

—

Other systemic involvement of connective tissue (FG)

162

2.62

7.96

1.0

1.1

6.37

6.61

mg/g

0.09

156

Benign intracranial hypertension

15.41

7.76

1.0

24.99

4.99

mg/g

—

Other systemic involvement of connective tissue

181

2.49

7.54

1.0

6.33

6.62

mg/g

0.11

174

Implicit bacterial Sepsis

196

2.34

7.52

1.1

10.34

8.39

mg/g

0.52

185

Diseases of inner ear

382

1.98

7.43

1.1

6.43

7.40

mg/g

0.72

359

SLE (Finngen)

10.92

7.30

1.1

1.0

8.72

6.40

mg/g

0.45

Pain in throat and chest

157

581

1.62

7.14

1.0

1.1

7.43

7.02

mg/g

0.11

149

557

Lower back pain or/and sciatica

181

758

1.56

7.10

1.1

6.46

6.84

mg/g

0.39

171

719

Asthma, excluding more controls

137

424

1.69

6.97

1.1

6.79

6.58

mg/g

0.14

127

410

Viral hepatitis, IBD co-morbidity

13.80

6.88

1.1

1.0

4.41

4.42

mg/g

—

Asthma

138

432

1.68

6.88

1.1

6.77

6.59

mg/g

0.13

128

417

Disorders of eyelid, lacrimal system and orbit

139

646

1.64

6.82

1.1

6.96

6.83

mg/g

0.09

133

609

Diseases of the musculoskeletal system and connective tissue

115

327

1.77

6.80

1.1

6.14

6.76

mg/g

0.30

110

316

Organic, including symptomatic, mental disorders

171

2.25

6.77

1.2

1.1

8.01

9.28

mg/g

0.62

166

Chronic rhinitis, nasopharyngitis and pharyngitis

321

2.03

6.73

1.2

1.0

5.36

6.33

mg/g

1.34

303

Abnormalities of breathing

166

612

1.58

6.68

1.0

1.1

6.43

6.91

mg/g

0.45

155

583

Other diseases of spinal cord

10.09

6.54

1.0

5.60

6.68

mg/g

0.41

Follow-up examination after treatment for conditions other than malignant neoplasms

277

1.91

6.51

1.0

1.1

6.14

6.11

mg/g

0.01

265

Infections with a predominantly sexual mode of transmission

514

1.76

6.47

1.1

1.0

5.94

6.19

mg/g

0.15

486

Asthma (mode)

134

435

1.65

6.39

1.1

6.68

6.59

mg/g

0.05

124

420

Other intervertebral disc disorders

134

493

1.64

6.36

1.1

7.57

6.54

mg/g

0.72

126

469

Postviral fatigue syndrome

18.45

6.30

1.0

4.45

5.61

mg/g

—

Chronic sinusitis

429

1.84

6.21

1.1

6.87

6.65

mg/g

0.11

403

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

296

2.02

6.19

1.1

5.40

6.28

mg/g

0.91

279

Exposure to other specified factors

138

801

1.58

6.16

1.1

6.67

6.99

mg/g

0.22

133

757

Cardiovascular diseases (excluding rheumatic etc)

150

546

1.58

6.14

1.1

6.06

6.33

mg/g

0.17

144

518

Triptan medication for migraine, min. 3 purchases

126

591

1.63

6.14

1.1

6.05

5.84

mg/g

0.14

119

558

Lumbar disc prolapse

103

462

1.71

6.06

1.1

7.98

6.68

mg/g

0.74

438

Metabolic disorders

153

598

1.56

6.03

1.1

8.03

6.81

mg/g

0.97

145

568

COPD differential diagnosis

139

435

1.60

5.84

1.1

6.41

6.59

mg/g

0.13

129

420

ILD differential diagnosis

139

435

1.60

5.84

1.1

6.41

6.59

mg/g

0.13

129

420

Other specific joint derangements/joint disorders

147

610

1.56

5.82

1.1

6.54

6.97

mg/g

0.27

137

586

Other meningitis

9.30

5.80

1.2

1.0

8.05

5.53

mg/g

0.41

Excluding asthma or asthma-COPD overlap

138

435

1.59

5.65

1.1

6.38

6.59

mg/g

0.15

128

420

Other pulmonary diagnosis

138

435

1.59

5.65

1.1

6.42

6.59

mg/g

0.12

128

420

Viral infections characterized by skin and mucous membrane lesions

148

831

1.52

5.57

1.1

8.11

6.71

mg/g

0.96

140

789

Acute upper respiratory infections

170

703

1.49

5.47

1.0

1.1

6.46

7.13

mg/g

0.51

156

673

Dyspnoea

141

677

1.54

5.46

1.0

1.1

5.82

6.95

mg/g

2.34

131

644

Bacterial Sepsis

223

2.03

5.45

1.1

11.00

8.23

mg/g

0.84

211

Systemic lupus erythematosus

6.24

5.39

1.1

1.0

8.72

5.92

mg/g

0.60

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

161

745

1.49

5.32

1.1

7.52

6.60

mg/g

0.74

154

707

Other disorders of optic disc

11.42

5.31

1.0

6.10

5.43

mg/g

—

Caries of enamel

162

788

1.48

5.27

1.1

7.27

6.81

mg/g

0.13

150

750

Voice disturbances

188

2.18

5.23

1.1

1.0

6.57

7.20

mg/g

0.29

177

Neuralgia and neuritis, unspecified

4.87

5.12

1.2

1.1

12.31

8.26

mg/g

0.34

SLE, strict definition

6.36

5.08

1.1

1.0

7.95

6.16

mg/g

0.33

SLE, ICD10

6.36

5.08

1.1

1.0

7.95

6.16

mg/g

0.33

Parasetamol

140

461

1.54

5.06

1.0

1.1

6.52

6.62

mg/g

0.05

135

440

Disorders of lipoprotein metabolism and other lipidaemias

107

408

1.62

5.06

1.0

1.1

8.32

7.38

mg/g

0.62

100

386

Asthma (only as main-diagnosis), excluding more controls

118

424

1.59

5.05

1.1

6.31

6.58

mg/g

0.22

111

410

Hypothyroidism, strict autoimmune

375

1.67

5.02

1.1

6.03

6.65

mg/g

0.51

360

Symptoms and signs concerning food and fluid intake

3.40

5.00

1.1

1.0

8.13

7.62

mg/g

0.07

Asthma (only as main-diagnosis)

118

432

1.58

4.94

1.1

6.31

6.59

mg/g

0.23

111

417

Bacterial meningitis

5.46

4.92

1.0

15.17

7.35

mg/g

1.44

Nephropathy related operations

2.87

4.91

1.2

1.0

11.62

9.32

mg/g

0.47

Infections with a predominantly sexual mode of transmission

418

1.75

4.90

1.2

1.0

6.22

5.64

mg/g

0.39

396

Immunodeficiency with predominantly antibody defects

6.53

4.78

1.3

1.0

6.04

5.69

mg/g

0.12

Care involving use of rehabilitation procedures

102

590

1.59

4.77

1.2

1.1

7.01

6.68

mg/g

0.17

558

All influenza

209

2.06

4.76

1.1

8.11

6.71

mg/g

0.57

201

Intestinal infectious diseases

157

818

1.46

4.75

1.1

7.00

6.98

mg/g

0.01

149

777

Obesity, other/unspecified

387

1.76

4.70

1.0

1.1

6.48

6.32

mg/g

0.10

362

Other external causes of accidental injury

142

472

1.51

4.69

1.1

7.12

6.62

mg/g

0.27

134

446

Autonomic disorders

8.25

4.57

1.2

1.0

9.29

6.05

mg/g

—

Diseases of the ear and mastoid process

200

717

1.40

4.55

1.1

6.40

7.09

mg/g

0.62

191

680

Acute sinusitis

583

1.57

4.45

1.0

1.1

6.36

6.81

mg/g

0.30

559

Sciatica+with lumbago

431

1.67

4.41

1.1

7.07

6.69

mg/g

0.19

408

Other disorders of central nervous system

11.82

4.29

1.3

1.0

4.92

5.68

mg/g

—

Cauda equina syndrome

11.81

4.28

1.0

9.93

6.80

mg/g

—

Dialysis, with operation codes

2.70

4.24

1.2

1.0

11.74

9.43

mg/g

0.45

Symptoms and signs involving the digestive system and abdomen

162

566

1.43

4.24

1.1

7.95

6.77

mg/g

0.39

152

542

Dissociative [conversion] disorders

4.14

4.21

1.0

4.62

5.58

mg/g

0.78

Accidents

139

472

1.48

4.20

1.1

7.04

6.62

mg/g

0.22

132

446

Asthma, unspecified (mode), excluding more controls

382

1.63

4.16

1.0

1.1

6.87

6.61

mg/g

0.13

368

Injuries to the wrist and hand

165

812

1.41

4.15

1.1

6.70

6.97

mg/g

0.17

157

770

Abdominal and pelvic pain

161

566

1.43

4.14

1.1

6.66

6.77

mg/g

0.07

154

542

Asthma, unspecified (mode)

386

1.62

4.11

1.0

1.1

6.87

6.61

mg/g

0.13

371

Persons encountering health services for examination and investigation

100

318

1.58

4.09

1.1

6.87

6.16

mg/g

0.43

305

Nystagmus and other irregular eye movements

8.10

4.07

1.0

5.10

mg/g

—

Benign neoplasms

170

667

1.41

4.07

1.1

6.85

6.68

mg/g

0.11

160

636

Dermatitis and eczema

179

800

1.39

4.06

1.1

6.55

7.07

mg/g

0.36

172

758

Mycoses

138

836

1.44

4.02

1.1

6.92

7.01

mg/g

0.05

127

798

Diarrhoea and gastroenteritis of presumed infectious origin

120

734

1.47

4.01

1.1

6.53

6.76

mg/g

0.16

113

697

Acute bronchitis

356

1.71

3.93

1.1

5.75

6.48

mg/g

1.02

342

Persons encountering health services for specific procedures and health care

179

778

1.38

3.93

1.1

7.35

6.80

mg/g

0.35

171

737

Pure hypercholesterolaemia

347

1.60

3.91

1.1

8.44

7.72

mg/g

0.37

327

Bacterial infection, other or unspecified

328

1.69

3.87

1.1

1.0

10.01

6.98

mg/g

1.25

313

Asthma-related infections

601

1.53

3.85

1.1

6.70

6.64

mg/g

0.03

569

Asthma, hospital admission 2, infections

601

1.53

3.85

1.1

6.70

6.64

mg/g

0.03

569

Asthma (diagnoses ohter than nonallergic)

140

819

1.42

3.81

1.1

6.60

6.91

mg/g

0.21

131

778

Other degenerative diseases of the basal ganglia

12.10

3.77

1.0

8.14

7.30

mg/g

—

Persistent mood disorders

147

2.11

3.73

1.0

1.1

5.79

7.52

mg/g

1.54

139

Neoplasms

151

567

1.41

3.72

1.1

7.83

5.94

mg/g

0.68

144

542

Dystonia

4.16

3.70

1.2

1.0

5.15

6.00

mg/g

0.56

Other congenital malformations of circulatory system

5.04

3.69

1.1

1.0

6.30

6.01

mg/g

—

Other and unspecified effects of external causes

318

1.73

3.69

1.1

5.72

6.31

mg/g

0.40

307

Cluster headache, strict

5.03

3.69

1.0

7.05

8.26

mg/g

—

Cluster headache, wide

5.02

3.69

1.0

7.05

8.26

mg/g

—

Herpesviral [herpes simplex] infections

260

1.81

3.66

1.2

1.0

7.04

5.93

mg/g

0.48

246

Other diseases of upper respiratory tract

169

639

1.38

3.63

1.1

6.68

7.09

mg/g

0.28

161

606

496

1.56

3.51

1.1

6.77

6.39

mg/g

0.18

470

Use of hypnotics and sedatives

166

696

1.37

3.51

1.1

6.92

6.87

mg/g

0.03

156

662

Other and unspecified immunodeficiencies with predominantly antibody defects

10.11

3.50

1.0

4.92

4.55

mg/g

—

Other specified/unspecified necrotizing vasculopathies

10.10

3.50

1.3

1.0

9.16

6.13

mg/g

—

Viral infections of central nervous system, not elsewhere classified/unspecified

10.09

3.50

1.0

7.14

6.01

mg/g

—

Psychotic depression

3.62

3.49

1.3

1.0

6.34

8.98

mg/g

0.84

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

140

606

1.40

3.40

1.1

7.63

6.91

mg/g

0.41

129

581

140

606

1.40

3.40

1.1

7.63

6.91

mg/g

0.41

129

581

Sleep disorders, other/unspecified

4.10

3.39

1.2

1.0

4.02

5.98

mg/g

2.32

Influenza and pneumonia

171

805

1.35

3.39

1.1

7.66

6.70

mg/g

0.72

158

768

Shoulder lesions

402

1.49

3.37

1.0

1.1

7.73

7.03

mg/g

0.37

386

Other specified/unspecified hearing loss

3.10

3.37

1.1

1.0

5.50

9.98

mg/g

2.03

Other and unspecified dermatitis

506

1.54

3.36

1.1

7.08

6.74

mg/g

0.11

476

Fall on same level

189

774

1.33

3.35

1.1

7.14

6.75

mg/g

0.26

177

736

Other facial nerve disorders

5.75

3.34

1.0

4.77

7.08

mg/g

—

Other specified/unspecified inflammatory spondylopathies

3.65

3.29

1.1

1.0

7.55

6.88

mg/g

0.08

Transport accidents

429

1.55

3.28

1.1

5.85

6.55

mg/g

0.41

405

Dermatitis

604

1.49

3.26

1.1

7.02

6.83

mg/g

0.07

568

Conjunctivitis

131

787

1.39

3.26

1.0

1.1

6.17

6.80

mg/g

0.54

126

744

Behavioural disorders

4.77

3.24

1.1

1.0

28.10

4.55

mg/g

—

Sleep disorders

145

765

1.37

3.23

1.1

6.35

7.00

mg/g

0.43

140

725

Dental pulpitis, including avohilmo

157

755

1.35

3.14

1.1

5.96

7.04

mg/g

1.33

144

723

Immunodeficiencies

3.44

3.10

1.3

1.0

7.14

5.41

mg/g

0.62

Other acute lower respiratory infections

507

1.50

3.08

1.1

6.73

6.83

mg/g

0.04

482

Other specified and unspecified strabismus

7.58

3.06

1.2

1.0

4.18

10.07

mg/g

—

Peroneal tendinitis

7.56

3.06

1.0

1.1

5.25

5.97

mg/g

—

Myeloid leukaemia

7.54

3.06

1.3

1.0

8.40

6.76

mg/g

—

Acute upper respiratory infections of multiple and unspecified sites

124

662

1.39

3.03

1.0

1.1

6.07

6.95

mg/g

0.77

113

632

Diseases of the respiratory system

104

360

1.45

2.98

1.0

1.1

6.99

6.31

mg/g

0.44

345

Somnolence

10.08

2.98

1.2

1.0

10.51

6.21

mg/g

—

Panhypopituitarism

10.06

2.98

1.2

1.0

5.18

7.59

mg/g

—

Circumscribed brain atrophy

10.05

2.98

1.0

9.25

8.23

mg/g

—

Coronary revascularization (ANGIO or CABG)

430

0.58

2.97

1.1

8.86

7.90

mg/g

0.27

408

Percutaneous Coronary Intervention

430

0.58

2.96

1.1

8.86

7.90

mg/g

0.27

408

Disorders of choroid and retina

466

1.45

2.93

1.1

7.84

7.52

mg/g

0.19

440

Behavioural syndromes associated with physiological disturbances and physical factors

148

782

1.34

2.93

1.1

6.49

6.97

mg/g

0.29

143

741

Falls/tendency to fall

179

681

1.32

2.92

1.1

6.86

6.58

mg/g

0.17

168

648

Bronchitis

164

780

1.32

2.91

1.1

6.11

7.13

mg/g

1.07

148

748

Superficial injury of abdomen, lower back and pelvis

128

2.03

2.90

1.1

1.0

7.51

6.93

mg/g

0.16

123

Disorders of vitreous body

307

1.64

2.90

1.0

1.1

7.38

7.89

mg/g

0.24

289

Constipation

120

599

1.39

2.90

1.1

7.72

6.72

mg/g

0.57

109

570

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

381

1.58

2.89

1.1

5.40

6.03

mg/g

0.61

366

Cluster headache, strict, including avohilmo

3.17

2.85

1.1

1.0

6.86

7.10

mg/g

0.06

Disturbances of smell and taste

4.46

2.79

1.1

4.80

6.29

mg/g

—

Dentofacial anomalies [including malocclusion]

124

731

1.36

2.77

1.0

1.1

6.25

6.86

mg/g

0.42

114

694

Injuries to the knee and lower leg

183

784

1.30

2.74

1.1

7.40

6.81

mg/g

0.43

176

742

Benign neoplasm: Rectum, anus and anal canal

2.20

2.73

1.2

1.1

8.37

9.02

mg/g

0.16

Human immunodeficiency virus [HIV] disease resulting in other conditions

6.04

2.70

1.0

11.41

6.37

mg/g

—

Cluster headache, wide,, including avohilmo

3.01

2.69

1.1

1.0

6.86

7.05

mg/g

0.05

Bacterial infection, other or unspecified

367

1.52

2.68

1.1

9.89

6.91

mg/g

1.27

351

Systemic lupus erythematosus, unspecified

4.23

2.68

1.0

5.84

6.16

mg/g

—

Injuries to the ankle and foot

122

801

1.35

2.67

1.0

1.1

7.64

6.63

mg/g

0.63

114

761

Emergency coronary revascularization (for ACS)

452

0.62

2.67

1.1

9.19

7.85

mg/g

0.42

430

Insomnia

140

768

1.33

2.63

1.1

6.41

6.96

mg/g

0.34

135

726

Perineal laceration during delivery

245

0.41

2.60

1.0

1.1

5.50

4.56

mg/g

0.69

234

Drug-induced osteoporosis

7.21

2.55

1.2

1.0

6.50

6.76

mg/g

—

Other and unspecified trigeminal disorders

7.19

2.55

1.4

1.0

6.77

5.76

mg/g

—

Human immunodeficiency virus [HIV] disease

5.49

2.55

1.0

11.41

6.16

mg/g

—

Disorders of vitreous body and globe

317

1.58

2.53

1.0

1.1

7.38

7.83

mg/g

0.21

298

Soft tissue disorders related to use, overuse and pressure

164

1.83

2.52

1.1

1.0

5.98

7.01

mg/g

0.72

157

Disorders of conjunctiva

133

806

1.32

2.51

1.0

1.1

6.26

6.80

mg/g

0.45

128

762

Osteopathies and chondropathies

473

1.46

2.51

1.1

6.76

7.05

mg/g

0.14

452

Obsessive-compulsive disorder

2.29

2.41

1.0

5.79

6.26

mg/g

0.19

Pneumonia, organism unspecified

133

707

1.32

2.40

1.1

8.27

6.52

mg/g

1.30

124

674

Open wound of lower leg

110

2.00

2.40

1.0

1.1

9.06

7.53

mg/g

0.29

105

Congenital malformations, deformations and chromosomal abnormalities

104

730

1.36

2.38

1.0

1.1

7.28

6.58

mg/g

0.40

691

Hypersomnia

6.30

2.37

1.0

7.53

6.30

mg/g

—

Finngen Rheumatological endpoints

158

696

1.29

2.37

1.1

6.61

6.92

mg/g

0.19

146

666

Diseases of spleen

6.29

2.37

1.2

1.0

5.84

5.81

mg/g

—

Asthma, including avohilmo

179

793

1.27

2.33

1.1

6.49

7.04

mg/g

0.50

166

756

Other joint disorders

152

619

1.30

2.31

1.1

6.45

6.96

mg/g

0.34

144

595

Other and unspecified iridocyclitis

3.22

2.30

1.0

7.14

6.17

mg/g

—

Rotator cuff syndrome

322

1.47

2.28

1.0

1.1

7.61

7.22

mg/g

0.20

310

Hypertension, essential

115

486

1.34

2.25

1.1

8.19

6.93

mg/g

0.92

105

460

Adrenocortical insufficiency

3.90

2.25

1.3

1.0

20.36

6.29

mg/g

—

Other salmonella infections

3.90

2.25

1.1

1.0

6.35

6.70

mg/g

—

Endocrine, nutritional and metabolic diseases

144

561

1.30

2.25

1.0

1.1

7.40

6.41

mg/g

0.68

135

531

Complications of medical and surgical care

665

1.36

2.23

1.1

6.51

6.89

mg/g

0.29

628

External causes of morbidity and mortality

107

395

1.36

2.23

1.0

1.1

6.76

6.64

mg/g

0.05

102

375

Delivery, wide proxy

225

0.54

2.23

1.1

1.0

5.75

5.55

mg/g

0.10

215

Rosacea

2.10

2.22

1.2

1.0

8.09

6.86

mg/g

0.34

Asthma, hospital admissions , main diagnosis only

124

838

1.31

2.19

1.1

6.42

6.97

mg/g

0.48

117

796

Benign neoplasm: Rectum

2.07

2.16

1.2

1.1

7.95

8.92

mg/g

0.25

Otitis externa, unspecified

2.03

2.15

1.1

1.0

5.33

7.53

mg/g

1.47

Viral conjunctivitis

4.31

2.15

1.0

4.54

5.95

mg/g

—

Other nutritional deficiencies

105

743

1.33

2.15

1.0

1.1

6.09

6.60

mg/g

0.60

100

704

Pregnancy, childbirth and the puerperium

191

0.52

2.13

1.1

1.0

5.41

5.30

mg/g

0.06

182

All pneumoniae

153

805

1.27

2.12

1.1

7.51

6.81

mg/g

0.46

143

768

Congenital malformations, deformations and chromosomal abnormalities

110

769

1.32

2.11

1.0

1.1

7.33

6.67

mg/g

0.38

103

727

Vertical strabismus

3.21

2.09

1.0

6.36

7.28

mg/g

—

Zoster [herpes zoster]

359

1.48

2.06

1.2

1.1

10.88

6.92

mg/g

1.30

340

Pneumonias (Asthma/COPD co-morbidities)

151

801

1.27

2.04

1.1

7.54

6.82

mg/g

0.46

141

764

Amblyopia ex anopsia

2.82

2.00

1.1

1.0

8.70

6.20

mg/g

—

Atopic dermatitis

107

668

1.31

1.98

1.0

1.1

5.63

6.54

mg/g

0.87

102

630

Benzodiazepine use

145

789

1.27

1.98

1.1

6.45

7.10

mg/g

0.50

139

749

Statin medication

116

499

1.31

1.97

1.1

7.53

6.97

mg/g

0.30

107

475

Intentional self-harm by unspecified means

4.58

1.94

1.4

1.0

6.59

5.04

mg/g

—

Torticollis

4.57

1.94

1.4

1.0

10.92

5.21

mg/g

—

Gastrointestinal diseases

108

410

1.32

1.93

1.1

6.05

6.70

mg/g

0.37

103

392

Other diseases of intestines

167

764

1.24

1.91

1.1

6.74

6.84

mg/g

0.05

155

727

Sequelae of injuries, of poisoning and of other consequences of external causes

212

1.61

1.87

1.0

1.1

6.15

7.05

mg/g

0.71

201

Myositis

3.54

1.84

1.2

1.0

7.61

6.55

mg/g

—

Other and unspecified acne

4.19

1.82

1.8

1.0

9.15

5.46

mg/g

—

Other and unspecified rosacea

2.27

1.80

1.2

1.1

7.88

7.65

mg/g

0.05

Post-traumatic stress disorder

1.92

1.80

1.1

1.0

5.23

5.57

mg/g

0.19

COPD/asthma related infections

151

606

1.25

1.77

1.0

1.1

6.24

6.91

mg/g

0.54

138

581

COPD/asthma/ILD related infections

151

606

1.25

1.77

1.0

1.1

6.24

6.91

mg/g

0.54

138

581

Event of undetermined intent

2.23

1.74

1.0

5.19

7.14

mg/g

1.00

Other salmonella infections

2.92

1.72

1.1

1.0

6.35

7.98

mg/g

—

Biological medicines for asthma

3.86

1.71

1.0

11.71

5.93

mg/g

—

Autoimmune thyroiditis

3.86

1.71

1.4

1.0

4.12

6.21

mg/g

—

Inflammatory diseases of female pelvic organs

530

1.30

1.69

1.1

5.39

5.70

mg/g

0.33

503

Cardiac arrhythmias

496

1.30

1.68

1.0

1.1

6.43

6.11

mg/g

0.19

472

Hypertensive diseases (excluding secondary)

382

1.32

1.67

1.0

1.1

7.81

6.33

mg/g

0.86

360

Social phobias

104

1.83

1.67

1.1

1.0

5.20

5.96

mg/g

0.43

104

Tobacco use

2.51

1.66

1.3

1.0

5.08

8.07

mg/g

—

Contact with sharp glass

2.59

1.66

1.1

1.0

4.28

6.90

mg/g

—

3.15

1.65

1.0

8.09

5.78

mg/g

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

143

789

1.24

1.65

1.1

7.73

6.79

mg/g

0.64

133

753

Disorders of orbit

2.81

1.65

1.3

1.0

10.13

6.05

mg/g

—

Reactive arthropathies, FINNGEN

2.44

1.64

1.0

1.1

11.07

7.14

mg/g

—

Anomalies of pupillary function

3.59

1.61

1.0

6.02

5.53

mg/g

—

Other protozoal intestinal diseases

3.59

1.61

1.0

4.48

5.50

mg/g

—

Melanocytic naevi

286

1.47

1.61

1.1

7.64

6.42

mg/g

0.65

273

Arthropathies

151

622

1.23

1.60

1.1

6.53

6.95

mg/g

0.26

145

598

Abnormal blood-pressure reading, without diagnosis

2.51

1.59

1.1

1.0

6.31

9.57

mg/g

—

Major coronary heart disease event

452

0.72

1.58

1.1

8.12

7.75

mg/g

0.12

429

Intentional self-harm by sharp object

3.01

1.58

1.0

5.52

5.24

mg/g

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.01

1.58

1.3

1.0

5.12

5.80

mg/g

—

Injury of nerves at wrist and hand level

2.70

1.58

1.0

4.35

7.90

mg/g

—

Other keratitis

1.82

1.57

1.1

1.0

4.66

7.54

mg/g

2.60

Other bacterial diseases

140

722

1.23

1.55

1.1

9.52

6.68

mg/g

2.37

129

688

Chronic conjunctivitis

3.34

1.52

1.4

1.0

5.01

5.71

mg/g

—

Alcohol abuse, main dg

138

1.67

1.51

1.3

1.0

7.24

7.42

mg/g

0.04

132

Brain meningioma, including Hilmo

2.86

1.50

1.0

9.58

7.04

mg/g

—

LSIL lesion of the cervix uteri

147

1.64

1.47

1.0

5.23

4.75

mg/g

0.35

142

Sleep disorders (combined)

161

700

1.21

1.46

1.1

6.27

7.04

mg/g

0.76

153

664

158

675

1.21

1.45

1.0

1.1

6.17

7.17

mg/g

0.94

144

647

Urolithiasis

203

1.53

1.45

1.0

1.1

8.05

7.82

mg/g

0.07

193

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.14

1.44

1.0

1.1

5.38

5.89

mg/g

—

Chronic Coagulation defects

3.14

1.44

1.0

6.47

6.06

mg/g

—

Polycystic kidney disease

3.14

1.44

1.2

1.0

14.20

8.15

mg/g

—

Unspecified event, undetermined intent

3.14

1.44

1.0

5.79

7.47

mg/g

—

Campylobacter enteritis

3.13

1.44

1.0

9.23

6.72

mg/g

—

Panniculitis affecting regions of neck and back

2.73

1.43

1.0

7.08

6.12

mg/g

—

Gingivitis and periodontal diseases

141

597

1.22

1.41

1.0

1.1

6.46

6.98

mg/g

0.43

127

574

Injury of muscle and tendon at lower leg level

103

1.75

1.40

1.1

8.82

8.17

mg/g

0.15

Diseases of external ear

304

1.42

1.39

1.1

7.10

6.83

mg/g

0.10

287

Olecranon bursitis

2.61

1.36

1.2

1.0

5.75

11.00

mg/g

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.95

1.36

1.0

1.1

4.73

6.09

mg/g

—

Burn and corrosion confined to eye and adnexa

2.95

1.36

1.0

6.33

6.31

mg/g

—

Other bacterial diseases

120

657

1.23

1.36

1.1

9.26

6.70

mg/g

2.07

109

630

Use of ropinirole

2.95

1.36

2.4

1.0

5.25

8.80

mg/g

—

Dental operations

343

0.73

1.31

1.1

6.99

7.43

mg/g

0.15

330

Injuries to the shoulder and upper arm

105

685

1.24

1.30

1.1

6.38

7.56

mg/g

1.25

655

Abscess of Bartholin gland

2.79

1.28

1.0

1.1

4.40

5.49

mg/g

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.78

1.28

1.2

1.0

3.98

6.45

mg/g

—

Other disorders of pigmentation

2.78

1.28

1.0

1.1

6.41

5.34

mg/g

—

Temporomandibular joint disorders, including avohilmo

570

1.28

1.0

1.1

6.40

5.73

mg/g

0.40

541

Chronic lower respiratory diseases

177

800

1.18

1.27

1.1

7.02

6.98

mg/g

0.02

166

761

Nail disorders

2.00

1.27

1.0

6.19

7.82

mg/g

0.57

Ingrowing nail

2.29

1.27

1.0

6.26

7.89

mg/g

—

Otitis externa

202

1.49

1.26

1.2

1.1

5.77

6.72

mg/g

0.49

192

Acute pancreatitis

115

1.65

1.24

1.2

1.0

7.62

7.91

mg/g

0.06

109

Acute pancreatitis (for exclusion)

115

1.65

1.24

1.2

1.1

7.62

8.11

mg/g

0.11

110

Menorrhagia

227

1.35

1.24

1.0

6.15

5.48

mg/g

0.31

216

Atrophic disorders of skin

100

1.70

1.23

1.1

5.44

7.00

mg/g

0.93

Maternal care for known or suspected fetal abnormality and damage

246

1.40

1.22

1.2

1.0

4.64

4.81

mg/g

0.19

226

Spasmodic torticollis

2.64

1.21

1.0

1.1

5.58

6.15

mg/g

—

Other specified and unspecified retinal disorders

2.64

1.21

1.0

1.1

9.35

5.98

mg/g

—

Alcohol-induced acute pancreatitis

2.64

1.21

1.0

11.41

9.34

mg/g

—

DVT of lower extremities

1.72

1.21

1.1

6.73

8.04

mg/g

0.45

Agoraphobia

2.31

1.18

1.0

4.21

5.50

mg/g

—

Ovarian cyst

259

1.31

1.16

1.1

1.0

4.79

5.30

mg/g

0.68

247

Disorders of synovium and tendon

443

1.29

1.16

1.0

1.1

7.62

6.48

mg/g

0.58

424

Congenital malformations of uterus and cervix

2.51

1.15

1.2

1.0

5.44

5.42

mg/g

—

Hypercalcemia

2.50

1.15

1.4

1.0

9.77

5.92

mg/g

—

Brain meningioma

2.50

1.15

1.0

1.1

4.74

7.07

mg/g

—

Malignant neoplasm, wide definition for exclusion

122

596

1.20

1.13

1.1

10.20

6.56

mg/g

1.17

114

563

Meniscus derangement

341

1.28

1.12

1.0

1.1

6.91

7.52

mg/g

0.36

326

Other disorders of adrenal gland

2.34

1.12

1.3

1.0

20.36

5.63

mg/g

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.96

1.11

1.1

1.0

5.08

6.96

mg/g

—

Obesity

727

1.22

1.09

1.0

1.1

6.28

6.48

mg/g

0.16

689

Burns and corrosions confined to eye and internal organs

2.39

1.09

1.0

6.33

6.56

mg/g

—

Cystic kidney disease

2.39

1.09

1.2

1.0

14.20

6.93

mg/g

—

Other epidermal thickening

2.38

1.09

1.0

8.23

6.24

mg/g

—

Phlebitis and thrombophlebitis (not including DVT)

152

1.51

1.08

1.1

1.0

6.65

7.73

mg/g

0.58

143

Hypertension

112

525

1.20

1.08

1.1

8.38

6.82

mg/g

1.16

102

498

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

120

644

1.19

1.07

1.1

6.51

7.18

mg/g

0.75

114

608

LSIL lesion of the cervix uteri, vagina or vulva

169

1.48

1.07

1.0

1.1

5.18

4.96

mg/g

0.14

161

Hypertensive diseases

112

526

1.20

1.06

1.1

8.38

6.82

mg/g

1.16

102

499

Obesity and other hyperalimentation

729

1.22

1.06

1.0

1.1

6.28

6.52

mg/g

0.21

691

All kidney diseases

137

796

1.18

1.05

1.1

7.41

6.54

mg/g

0.62

123

763

Contact with and exposure to communicable diseases

474

0.73

1.04

1.1

5.43

5.70

mg/g

0.18

452

Postprocedural disorders of digestive system, not elsewhere classified

2.28

1.03

1.2

1.0

11.33

7.71

mg/g

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

124

687

1.18

1.03

1.1

6.21

6.48

mg/g

0.21

117

652

Haemorrhage in early pregnancy

350

0.69

1.03

1.1

1.0

4.20

5.27

mg/g

2.78

326

Cystic kidney disease

2.18

0.98

1.2

1.0

14.20

6.97

mg/g

—

Convergent concomitant strabismus

1.77

0.94

1.1

1.0

4.03

7.71

mg/g

—

Acute lymphadenitis

1.77

0.94

1.1

1.0

5.10

6.88

mg/g

—

Diseases of tongue

1.89

0.94

1.1

1.0

7.38

7.72

mg/g

—

Hypothyroidism, other/unspecified

120

673

1.17

0.92

1.1

6.25

6.46

mg/g

0.16

113

639

Disease of hard tissues of teeth, NOS

291

1.24

0.91

1.1

6.19

7.42

mg/g

0.81

281

Injuries to the head

154

824

1.15

0.90

1.1

6.91

mg/g

0.00

148

780

Tongue abnormality

2.07

0.89

1.2

1.0

7.42

6.23

mg/g

—

Ischemic heart diseases

473

0.81

0.88

1.1

7.67

7.63

mg/g

0.01

450

Hordeolum and other deep inflammation of eyelid

1.86

0.87

1.4

1.0

6.02

8.46

mg/g

—

Acute alcohol intoxication

220

1.36

0.87

1.2

1.1

6.96

7.53

mg/g

0.18

207

Deviated nasal septum

263

1.33

0.86

1.1

9.09

7.97

mg/g

0.34

248

Hyperkinetic disorders

199

1.38

0.86

1.0

1.1

4.53

5.46

mg/g

1.25

194

Nonischemic cardiomyopathy

1.74

0.82

1.0

5.31

9.12

mg/g

—

Viral conjunctivitis

1.88

0.82

1.0

4.54

8.01

mg/g

—

Open wound of hip and thigh

0.00

0.79

0.0

1.0

—

7.24

—

Prepatellar bursitis

0.00

0.79

0.0

1.0

—

10.62

—

160

0.63

0.77

1.2

1.1

12.70

9.02

mg/g

0.32

150

Malignant neoplasm of digestive organs

138

0.63

0.76

1.3

1.1

12.87

8.16

mg/g

0.45

129

Hypertrophy of breast

162

0.62

0.76

1.0

5.42

5.81

mg/g

—

151

Any event in cancer register

129

663

1.15

0.76

1.1

9.94

6.33

mg/g

1.28

123

628

Cardiodefibrillation

161

0.62

0.75

1.1

1.0

12.17

9.13

mg/g

—

152

Gingival hyperplasia

2.09

0.74

1.0

3.32

6.39

mg/g

—

Exclusions for E4_PCOS_CONSORTIUM

109

591

1.16

0.74

1.1

6.32

5.69

mg/g

0.53

564

Cardiomyopathy, other and unspecified

1.84

0.73

1.1

9.04

9.26

mg/g

—

Fitting and adjustment of other devices

166

0.65

0.72

1.3

1.1

7.03

8.57

mg/g

0.60

155

Other surgical follow-up care

2.00

0.72

1.0

5.30

6.93

mg/g

—

Skin changes due to chronic exposure to nonionizing radiation

147

0.63

0.72

1.2

1.1

13.70

9.04

mg/g

—

138

Mental and behavioural disorders due to alcohol

460

1.21

0.72

1.1

6.59

7.52

mg/g

0.67

438

Biomechanical lesions, not elsewhere classified

1.93

0.70

1.6

1.0

6.94

6.67

mg/g

—

Medical abortion

418

1.17

0.69

1.0

1.1

5.38

5.69

mg/g

0.25

394

Benign neoplasm: Long bones of lower limb

1.85

0.68

1.0

4.95

7.81

mg/g

—

!Aliquae complicationes praecoces traumatis

1.85

0.68

1.4

1.0

5.42

8.74

mg/g

—

Early complications of trauma

1.85

0.68

1.4

1.0

5.42

8.74

mg/g

—

Special screening examination for neoplasms

1.85

0.68

1.0

1.1

6.90

9.26

mg/g

—

Inflammatory diseases of prostate (prostatitis)

1.60

0.68

1.0

9.13

9.48

mg/g

0.03

Gastro-oesophageal reflux disease

590

1.17

0.68

1.1

6.27

7.14

mg/g

0.63

558

Acute alcohol intoxication, ICD10

196

1.33

0.67

1.2

1.1

7.19

7.03

mg/g

0.04

188

Sleep apnoea

112

635

1.14

0.67

1.1

7.00

7.57

mg/g

0.41

105

601

Diseases of the skin and subcutaneous tissue

143

637

1.13

0.66

1.1

6.90

6.91

mg/g

0.00

136

602

Corneal ulcer

179

0.67

0.66

1.2

1.1

8.07

7.26

mg/g

0.16

168

Iridocyclitis

188

1.33

0.66

1.0

1.1

6.13

7.15

mg/g

0.58

177

Chronic kidney disease

134

1.39

0.65

1.1

1.0

9.86

8.58

mg/g

0.27

128

Primary open-angle glaucoma

116

1.42

0.64

1.1

9.87

8.71

mg/g

0.25

108

Other acquired deformities of musculoskeletal system and connective tissue

1.73

0.64

1.4

1.0

9.44

8.66

mg/g

—

497

1.18

0.64

1.1

6.98

7.82

mg/g

0.46

473

Malignant neoplasm

109

566

1.14

0.63

1.1

10.79

6.65

mg/g

1.21

102

535

Actinic keratosis

142

0.65

0.62

1.2

1.0

13.70

9.18

mg/g

—

133

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

1.67

0.61

1.2

1.0

4.44

5.84

mg/g

—

Dermatophytosis

646

1.16

0.60

1.1

7.42

7.10

mg/g

0.13

614

Erosion of teeth , including avohilmo

307

1.24

0.60

1.1

6.25

6.31

mg/g

0.02

296

0.00

0.60

0.0

1.0

—

4.85

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.60

0.0

1.1

—

6.04

—

Complications associated with artificial fertilization

0.00

0.60

0.0

1.0

—

5.42

—

Seronegative juvenile rheumatoid arthritis

0.00

0.58

0.0

1.0

—

4.15

—

Injury of eye and orbit

149

1.34

0.57

1.0

1.1

7.81

7.49

mg/g

0.06

144

Acute tubulo-interstitial nephritis

520

1.16

0.57

1.1

5.86

6.68

mg/g

1.15

495

Schizophrenia

161

0.68

0.57

1.0

4.89

7.11

mg/g

2.21

154

Postmenopausal atrophic vaginitis

115

1.30

0.56

1.1

8.28

6.60

mg/g

0.45

109

Alcohol use disorder, ICD-based

374

1.20

0.56

1.1

6.77

7.48

mg/g

0.35

354

Polyarthropathies

504

1.14

0.55

1.0

1.1

7.47

6.98

mg/g

0.27

485

AV-block

1.51

0.55

1.0

1.1

5.93

8.72

mg/g

1.71

Pacemaker

119

0.64

0.54

1.0

1.1

6.20

8.94

mg/g

—

114

Dipeptidyl peptidase 4 (DPP-4) inhibitors

272

0.79

0.53

1.0

1.1

11.13

8.13

mg/g

0.65

252

Other and unspecified anaemias

220

1.26

0.53

1.2

1.1

8.99

8.10

mg/g

0.14

207

Foreign body in alimentary tract

1.54

0.53

1.0

3.80

8.52

mg/g

—

Hypertrophy of breast in women and men

181

0.72

0.52

1.0

6.45

6.39

mg/g

0.02

170

Acute pharyngitis

187

1.27

0.50

1.1

5.16

6.17

mg/g

0.82

182

Other anaemias

223

1.24

0.48

1.2

1.0

8.99

8.06

mg/g

0.14

210

Caught, crushed, jammed or pinched in or between objects

1.49

0.47

1.0

6.50

7.58

mg/g

—

Leiomyoma of uterus

369

1.14

0.46

1.1

8.43

5.81

mg/g

1.46

346

Kidney transplant status

1.43

0.46

1.1

1.0

8.95

9.05

mg/g

—

Excessive earwax

450

0.85

0.45

1.1

8.49

7.25

mg/g

0.44

429

Anterior Iridocyclitis

165

1.27

0.44

1.0

6.58

7.04

mg/g

0.19

156

Diseases of oesophagus, stomach and duodenum

138

755

1.09

0.44

1.1

7.26

6.73

mg/g

0.33

130

718

Monoamine oxidase A inhibitors

1.45

0.44

1.0

6.27

9.11

mg/g

—

Chronic apical periodontitis

149

779

1.09

0.44

1.1

6.76

6.92

mg/g

0.09

137

742

Nontoxic goitre/thyroid nodule

208

0.77

0.43

1.0

1.1

8.63

7.11

mg/g

0.26

194

Chronic iridocyclitis

1.61

0.43

1.0

4.56

5.95

mg/g

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

103

1.34

0.42

1.0

1.1

8.99

8.31

mg/g

0.17

Other and unspecified injuries of wrist and hand

1.56

0.42

1.0

4.96

5.52

mg/g

—

Caries of dentine, including avohilmo

452

0.89

0.42

1.1

7.14

6.89

mg/g

0.10

434

Ankylosing spondylitis, strict definition

1.52

0.41

1.0

5.10

9.47

mg/g

—

Dependent personality disorder

0.00

0.41

0.0

1.0

—

6.57

—

Oral leukoplakia, including avohilmo

0.00

0.41

0.0

1.0

—

6.37

—

Other secondary coxarthrosis

0.00

0.41

0.0

1.1

—

6.36

—

Atrial septal defect, secundum type

1.51

0.41

1.0

1.1

4.57

5.48

mg/g

—

Schizotypal disorder

0.00

0.41

0.0

1.0

—

6.52

—

Short Achilles tendon (acquired)

0.00

0.41

0.0

1.0

—

6.23

—

Infective bursitis

0.00

0.41

0.0

1.0

—

11.25

—

Burn and corrosion of trunk

0.00

0.41

0.0

1.0

—

6.27

—

Benign neoplasm of thyroid gland

0.00

0.41

0.0

1.1

—

6.56

—

Ovarian hyperstimulation (induction)

0.00

0.40

0.0

1.0

—

5.21

—

Periodontal disease, other/unspecified

0.00

0.40

0.0

1.0

—

6.19

—

Other benign neoplasms of uterus

0.00

0.40

0.0

1.1

—

7.37

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

406

1.15

0.40

1.1

6.63

7.63

mg/g

0.58

386

Complications of surgical and medical care, not elsewhere classified

121

760

1.09

0.39

1.1

6.22

6.92

mg/g

0.88

115

722

Crohn disease (strict definition, all UC cases excluded)

1.43

0.39

1.0

4.35

7.00

mg/g

—

Cellulitis

187

1.23

0.38

1.2

1.0

12.74

7.10

mg/g

0.87

177

Kela-code for severe mental illness

410

0.85

0.38

1.1

5.02

7.15

mg/g

2.60

387

Disorders of the thyroid gland

119

712

1.09

0.37

1.1

6.25

6.52

mg/g

0.20

112

674

Hypertrophic scar

1.35

0.37

1.0

6.16

6.19

mg/g

—

HSIL lesion of the cervix uteri, vagina or vulva

268

0.82

0.37

1.0

1.1

4.96

5.08

mg/g

0.07

252

Other heart diseases, wide

133

752

1.08

0.36

1.0

1.1

6.39

7.00

mg/g

0.47

127

717

Polycystic ovarian syndrome, broad definition

168

0.77

0.35

1.0

1.1

4.67

4.69

mg/g

0.01

163

Fracture of skull and facial bones

217

1.20

0.35

1.1

6.18

7.17

mg/g

0.69

207

Abnormalities of forces of labour

123

0.73

0.35

1.0

1.1

4.86

5.46

mg/g

—

114

Alcohol dependence

208

1.20

0.35

1.1

6.02

8.46

mg/g

2.65

195

Iron deficiency anaemia secondary to blood loss (chronic)

1.34

0.34

1.2

1.1

5.35

7.66

mg/g

1.02

Colorectal cancer

0.70

0.33

1.2

1.1

6.73

8.71

mg/g

—

Alcohol use disorder, Swedish definition

459

1.12

0.32

1.1

7.06

7.44

mg/g

0.17

436

Other diseases of anus and rectum

198

0.81

0.32

1.0

8.38

7.68

mg/g

0.13

187

Hernia

111

690

1.08

0.30

1.1

8.54

7.32

mg/g

0.56

102

655

Asthma/COPD (KELA code 203)

125

799

1.07

0.30

1.1

6.77

6.98

mg/g

0.11

117

761

Benign neoplasm: Colon, unspecified

120

1.25

0.30

1.1

10.19

9.05

mg/g

0.12

111

Acute and subacute iridocyclitis

157

1.21

0.29

1.0

1.1

6.80

7.24

mg/g

0.16

147

529

1.10

0.29

1.1

6.99

7.66

mg/g

0.36

503

Seborrhoeic keratosis

108

0.74

0.29

1.3

1.1

14.25

8.59

mg/g

—

Labour and delivery complicated by fetal stress [distress]

289

0.88

0.29

1.1

5.16

5.12

mg/g

0.02

271

Sleep apnoea, including avohilmo

119

689

1.07

0.27

1.1

6.68

7.42

mg/g

0.64

113

652

Congenital malformations and deformations of the musculoskeletal system

139

1.22

0.27

1.1

8.07

5.79

mg/g

0.34

134

Poor fetal growth

183

0.82

0.27

1.2

1.0

4.49

4.73

mg/g

0.24

177

Diseases of pulp and periapical tissues, including avohilmo

141

687

1.06

0.27

1.1

6.46

7.06

mg/g

0.42

132

659

Glucosamine medication

189

0.84

0.27

1.1

7.19

9.13

mg/g

1.10

176

Other abnormal uterine and vaginal bleeding

154

0.84

0.26

1.0

5.71

5.59

mg/g

0.06

147

Dysplasia of cervi uteri

231

1.13

0.25

1.0

4.86

5.08

mg/g

0.18

220

HSIL lesion of the cervix uteri

255

0.86

0.24

1.0

1.1

4.96

5.03

mg/g

0.04

240

Hallux valgus (acquired)

183

0.86

0.23

1.0

1.1

5.61

6.82

mg/g

0.87

174

Fentanyl

1.31

0.23

1.0

12.44

8.89

mg/g

—

Nontoxic single thyroid nodule

1.28

0.23

1.0

1.1

10.30

7.34

mg/g

—

Other disorders of penis

1.27

0.22

1.1

5.71

8.28

mg/g

—

Aplastic and other anaemias

248

1.13

0.22

1.2

1.0

8.84

7.88

mg/g

0.15

234

Hypertrophic disorders of skin

1.22

0.22

1.0

6.16

5.97

mg/g

—

Renal tubulo-interstitial diseases

100

701

1.06

0.21

1.1

7.52

6.50

mg/g

0.58

667

Ectopic testis

0.00

0.21

0.0

1.1

—

6.77

—

Other congenital malformations of limb(s)

0.00

0.21

0.0

1.0

—

5.33

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

6.15

—

HSIL lesion of the vagina

0.00

0.21

0.0

1.0

—

6.58

—

Whooping cough

0.00

0.21

0.0

1.0

—

4.73

—

Donors of organs and tissues

0.00

0.21

0.0

1.0

—

5.69

—

Open wound of thorax

0.00

0.21

0.0

1.0

—

6.07

—

HSIL lesion of the vulva

0.00

0.21

0.0

1.0

—

6.02

—

Other infestations

0.00

0.21

0.0

1.0

—

5.33

—

Adhesive middle ear disease

0.00

0.21

0.0

1.0

—

5.61

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.0

—

5.42

—

Infliximab

0.00

0.21

0.0

1.0

—

5.94

—

Tularaemia

0.00

0.21

0.0

1.0

—

7.15

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

1.0

—

6.56

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

0.21

0.0

1.0

—

6.80

—

Diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

6.11

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.21

0.0

1.0

—

9.32

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.0

—

6.11

—

Patellar tendinitis

0.00

0.21

0.0

1.0

—

9.55

—

Anxious personality disorder

0.00

0.21

0.0

1.0

—

5.60

—

conjunctival degenerations and deposits

0.00

0.21

0.0

1.0

—

6.82

—

Other conjunctival vascular disorders and cysts

0.00

0.21

0.0

1.0

—

6.79

—

Oral lichen planus

0.00

0.21

0.0

1.0

—

6.32

—

Hyperaldosteronism

0.00

0.21

0.0

1.0

—

7.31

—

Problems related to social environment

0.00

0.21

0.0

1.0

—

9.12

—

Periodontitis

108

682

1.06

0.21

1.1

7.39

7.14

mg/g

0.15

650

Complex cardiac defects

0.00

0.21

0.0

1.0

—

7.25

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.21

0.0

1.1

—

7.31

—

Unspecified maternal hypertension

0.00

0.21

0.0

1.0

—

5.68

—

Toxic effect of alcohol

0.00

0.21

0.0

1.0

—

6.63

—

Intussusception

0.00

0.21

0.0

1.1

—

6.15

—

Follicular lymphoma, hilmo

0.00

0.21

0.0

1.0

—

7.75

—

Congenital malformations of cardiac chambers and connections

0.00

0.20

0.0

1.0

—

6.72

—

Other congenital malformations of male genital organs

0.00

0.20

0.0

1.1

—

6.51

—

Other congenital malformations of male genital organs

0.00

0.20

0.0

1.1

—

6.51

—

Coarctation of the aorta

0.00

0.20

0.0

1.0

—

5.87

—

Benign neoplasm: Tongue

0.00

0.20

0.0

1.0

—

6.52

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

125

774

1.05

0.19

1.1

6.60

6.69

mg/g

0.06

118

735

Chronic periodontitis, including avohilmo

107

681

1.05

0.18

1.1

7.41

7.14

mg/g

0.15

649

Other abnormal products of conception

320

1.08

0.17

1.1

4.83

5.05

mg/g

0.27

301

Conduction disorders

145

1.12

0.14

1.1

6.07

8.19

mg/g

1.54

138

Endometriosis

252

1.07

0.14

1.1

1.0

7.20

5.34

mg/g

0.97

241

Spondylolisthesis/Spondylolysis

0.81

0.13

1.0

1.1

6.58

6.84

mg/g

—

L02BA Anti-estrogens

110

0.82

0.13

1.1

5.24

6.08

mg/g

—

100

Type 2 diabetes, definitions combined, including avohilmo

112

628

1.04

0.12

1.0

1.1

8.07

6.81

mg/g

1.14

107

592

Foreign body on external eye

137

0.88

0.12

1.0

8.28

8.18

mg/g

0.02

132

Hypothyroidism, strict autoimmune, 3 medication purchases required

637

1.04

0.11

1.1

6.06

6.25

mg/g

0.15

603

Solid cancers, helper endpoint

552

1.04

0.11

1.1

10.46

6.71

mg/g

0.95

521

Early lumbar disc prolapse operation

136

0.88

0.11

1.0

1.1

5.76

6.47

mg/g

0.29

131

Infections of the skin and subcutaneous tissue

675

1.04

0.10

1.2

1.1

8.48

6.88

mg/g

0.65

639

In situ neoplasms

280

0.93

0.10

1.2

1.1

8.92

6.66

mg/g

0.46

262

Cholelithiasis, broad definition with cholecystitis

586

0.96

0.10

1.1

7.33

7.02

mg/g

0.13

551

Disorders of breast

504

0.95

0.10

1.0

1.1

4.73

5.98

mg/g

2.86

478

Cholelithiasis

579

0.96

0.10

1.1

7.39

7.04

mg/g

0.16

544

Nontoxic multinodular goitre

114

0.88

0.09

1.0

1.1

8.34

6.88

mg/g

—

105

Benign neoplasm: Sigmoid colon

1.15

0.09

1.0

1.1

14.21

8.56

mg/g

—

Carpal tunnel syndrome

464

1.04

0.09

1.0

1.1

7.55

7.17

mg/g

0.16

444

Diseases of pulp and periapical tissues and dental caries

360

1.04

0.09

1.1

7.20

7.32

mg/g

0.04

348

Missing teeth due to accident, extraction or parodontitis

413

1.05

0.09

1.1

7.80

7.90

mg/g

0.03

392

Ectopic pregnancy

196

0.92

0.09

1.1

6.11

5.66

mg/g

0.22

185

Crohn disease (strict definition, require KELA, min 2 HDR)

1.11

0.09

1.0

4.35

7.66

mg/g

—

Crohn disease (strict definition, require KELA)

1.11

0.09

1.0

4.35

7.66

mg/g

—

Foreign body or object entering through skin

1.09

0.09

1.0

7.58

9.01

mg/g

—

Disorders of gallbladder, biliary tract and pancreas

107

656

1.03

0.08

1.1

7.43

6.98

mg/g

0.25

101

620

Fracture of shoulder and upper arm

312

1.06

0.08

1.1

5.90

6.89

mg/g

0.75

298

Diseases of appendix

797

1.03

0.08

1.1

6.91

7.00

mg/g

0.04

757

Cutaneous abscess, furuncle and carbuncle

276

0.94

0.07

1.0

1.1

7.33

6.38

mg/g

0.53

264

Other disorders of breast

108

1.11

0.07

1.0

1.1

4.12

5.65

mg/g

1.71

102

Other disorders of ear

100

638

1.03

0.07

1.1

7.37

7.19

mg/g

0.09

608

Heart failure and antihypertensive medication

1.09

0.07

1.2

1.1

6.51

8.83

mg/g

1.19

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.02

0.07

1.0

4.96

8.00

mg/g

—

Carbimazole or st.post thyroidectomy, condition for graves disease

177

1.07

0.06

1.2

1.0

7.99

6.47

mg/g

0.38

167

Appendicitis, broad definition

794

1.02

0.06

1.1

6.90

7.01

mg/g

0.05

754

All dysplastic lesions of the cervix uteri

371

1.04

0.06

1.0

1.1

5.00

5.04

mg/g

0.03

347

Early lumbar disc prolapse, operated

109

1.10

0.06

1.0

1.1

5.76

5.81

mg/g

0.02

104

Diseases of oral cavity, salivary glands and jaws

294

1.03

0.05

1.0

1.1

7.78

7.38

mg/g

0.13

284

Primary open-angle glaucoma, strict

100

1.10

0.05

1.1

9.06

8.24

mg/g

0.17

Gonarthrosis [arthrosis of knee](FG)

370

0.97

0.05

1.0

1.1

6.82

7.84

mg/g

0.60

351

Pregnancy examination and test

163

0.95

0.04

1.0

6.30

5.25

mg/g

0.30

152

Glucagon-like peptide-1 (GLP-1) analogues

231

0.95

0.04

1.0

1.1

10.30

7.67

mg/g

0.58

213

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

231

0.95

0.04

1.0

1.1

10.30

7.67

mg/g

0.58

213

Other (seronegative) rheumatoid arthritis, wide

111

1.08

0.04

1.0

1.1

6.00

7.62

mg/g

1.18

102

Gonarthrosis,primary

426

0.98

0.02

1.0

1.1

7.20

7.98

mg/g

0.46

402

Arthrosis

406

0.99

0.02

1.1

7.26

7.39

mg/g

0.05

390

Antepartum haemorrhage, not elsewhere classified

133

1.05

0.01

1.0

4.31

5.04

mg/g

0.88

125

Psoriasis vulgaris

143

1.05

0.01

1.1

8.96

6.99

mg/g

0.40

133

Necrosis of pulp, including avohilmo

696

0.99

0.01

1.1

6.28

6.65

mg/g

0.19

659

Myocardial infarction, without ST-elevation

149

1.04

0.01

1.2

1.1

8.60

9.16

mg/g

0.13

141

Dental caries, including avohilmo

395

1.01

0.01

1.1

6.96

7.21

mg/g

0.10

381

Redundant prepuce, phimosis and paraphimosis

204

0.97

0.00

1.1

9.08

9.86

mg/g

0.17

194

Combinations of oral blood glucose lowering drugs

157

1.02

0.00

1.0

1.1

8.62

8.66

mg/g

0.01

144

Postpartum haemorrhage due to anatomy

138

1.01

0.00

1.0

1.1

3.81

4.64

mg/g

1.41

133

Gestational [pregnancy-induced] hypertension

364

1.01

0.00

1.0

4.88

5.16

mg/g

0.31

341

Acute appendicitis

781

1.00

0.00

1.1

6.95

6.98

mg/g

0.01

742

Hernia of abdominal wall

374

0.99

0.00

1.1

10.22

7.22

mg/g

0.59

356

All dysplastic lesions of the cervix uteri, vagina or vulva

402

1.00

0.00

1.0

5.20

5.25

mg/g

0.03

376

Other diseases of hard tissues of teeth

294

1.00

0.00

1.1

6.50

7.38

mg/g

0.47

284

Artrosis, including avohilmo

531

1.00

0.00

1.1

6.31

7.56

mg/g

1.08

507

Other noninflammatory disorders of uterus, except cervix

106

1.02

0.00

1.0

1.1

9.65

6.04

mg/g

0.68

100

Diseases of arteries, arterioles and capillaries

329

0.99

0.00

1.1

8.63

8.11

mg/g

0.18

311

Kyphosis

0.00

0.0

1.0

—

7.61

—

Benign neoplasm of breast

1.01

0.00

1.3

1.0

4.85

5.68

mg/g

—

Flatulence and related conditions

0.00

0.0

1.0

—

7.36

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

7.20

—

Measles

0.00

0.0

1.0

—

6.27

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.0

—

8.75

—

Trichomoniasis

0.00

0.0

1.0

—

5.76

—

Female infertility, uterine origin

0.00

0.0

1.0

—

6.90

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.0

—

3.04

—

Other congenital malformations of urinary system

0.00

0.0

1.0

—

4.44

—

Benign neoplasm: Bronchus and lung

0.00

0.0

1.0

—

7.59

—

Guttate psoriasis

0.00

0.0

1.0

—

6.57

—

Exfoliative dermatitis

0.00

0.0

1.0

—

6.92

—

Diseases caused by chlamydiae

0.00

0.0

1.0

—

5.87

—

Morphin

0.00

0.0

1.0

—

8.54

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

7.32

—

Intentional self-harm by jumping from a high place

0.00

0.0

1.0

—

4.95

—

Hypertrophy of (infrapatellar) fat pad

0.00

0.0

1.0

—

7.57

—

Amputation of ankle bones

0.00

0.0

1.0

—

7.04

—

Transient synovitis

0.00

0.0

1.0

—

11.44

—

Other bursitis of hip

0.00

0.0

1.0

—

7.11

—

Discitis, unspecified

0.00

0.0

1.0

—

6.58

—

Moderate mental retardation

0.00

0.0

1.0

—

4.16

—

Injury of cranial nerves

0.00

0.0

1.0

—

6.60

—

Cicatricial alopecia [scarring hair loss]

0.00

0.0

1.0

—

7.20

—

Endometriosis of fallopian tube

0.00

0.0

1.0

—

6.57

—

Assault by other specified means

0.00

-0.00

0.0

1.0

—

6.16

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

0.00

-0.00

0.0

1.0

—

5.96

—

Hypothyroidism due to medicaments and other exogenous substances

0.00

-0.00

0.0

1.0

—

7.24

—

Exposure to unspecified smoke, fire and flames

0.00

-0.00

0.0

1.0

—

6.92

—

Cutaneous lupus erythematosus

0.00

-0.00

0.0

1.0

—

5.72

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

-0.00

0.0

1.0

—

7.67

—

Combined immunodeficiencies

0.00

-0.00

0.0

1.0

—

6.04

—

Lifestyle-related condition

0.00

-0.00

0.0

1.0

—

6.17

—

Orthopaedic devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

6.50

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.0

—

3.33

—

Other immunodeficiencies

0.00

-0.00

0.0

1.0

—

4.52

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

5.24

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

1.0

—

5.29

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin in CSF/Albumin in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS